BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Srivastava SP, Zhou H, Setia O, Dardik A, Fernandez-Hernando C, Goodwin J. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus. J Am Heart Assoc 2021;10:e019437. [PMID: 34308664 DOI: 10.1161/JAHA.120.019437] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Wan J, Liu D, Pan S, Zhou S, Liu Z. NLRP3-mediated pyroptosis in diabetic nephropathy. Front Pharmacol 2022;13:998574. [DOI: 10.3389/fphar.2022.998574] [Reference Citation Analysis]
2 Liu Y, Zheng J, Wei Z, Liu S, Sun J, Mao Y, Xu Y, Yang Y. Therapeutic effect and mechanism of combination therapy with ursolic acid and insulin on diabetic nephropathy in a type I diabetic rat model. Front Pharmacol 2022;13:969207. [DOI: 10.3389/fphar.2022.969207] [Reference Citation Analysis]
3 Liu T, Yang L, Mao H, Ma F, Wang Y, Li S, Li P, Zhan Y. Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases. Biomed Pharmacother 2022;155:113620. [PMID: 36122519 DOI: 10.1016/j.biopha.2022.113620] [Reference Citation Analysis]
4 Liu T, Mu S, Yang L, Mao H, Ma F, Wang Y, Zhan Y. Comprehensive bibliometric analysis of sirtuins: Focus on sirt1 and kidney disease. Front Pharmacol 2022;13:966786. [DOI: 10.3389/fphar.2022.966786] [Reference Citation Analysis]
5 Li X, Xu B, Wu J, Pu Y, Wan S, Zeng Y, Wang M, Luo L, Zhang F, Jiang Z, Xu Y, Srivastava S. Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/7177889] [Reference Citation Analysis]
6 Alexandrou M, Theodorakopoulou MP, Sarafidis PA. Role of Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Kidney and Dialysis 2022;2:163-182. [DOI: 10.3390/kidneydial2020019] [Reference Citation Analysis]
7 Srivastava SP, Kanasaki K. Editorial: Receptor Biology and Cell Signaling in Diabetes. Front Pharmacol 2022;13:864117. [PMID: 35370643 DOI: 10.3389/fphar.2022.864117] [Reference Citation Analysis]
8 Wang H, Karnati S, Madhusudhan T. Regulation of the Homeostatic Unfolded Protein Response in Diabetic Nephropathy. Pharmaceuticals 2022;15:401. [DOI: 10.3390/ph15040401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cheng L, Qiu X, He L, Liu L. MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway. Ren Fail 2022;44:293-303. [PMID: 35166173 DOI: 10.1080/0886022X.2022.2039194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Riffo-Campos AL, Perez-Hernandez J, Ortega A, Martinez-Arroyo O, Flores-Chova A, Redon J, Cortes R. Exosomal and Plasma Non-Coding RNA Signature Associated with Urinary Albumin Excretion in Hypertension. Int J Mol Sci 2022;23:823. [PMID: 35055008 DOI: 10.3390/ijms23020823] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shelke V, Kale A, Sankrityayan H, Anders HJ, Gaikwad AB. Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease. Arch Physiol Biochem 2022;:1-12. [PMID: 34986074 DOI: 10.1080/13813455.2021.2023580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Przybyciński J, Drożdżal S, Domański L, Dziedziejko V, Pawlik A. Role of Endothelial Glucocorticoid Receptor in the Pathogenesis of Kidney Diseases. Int J Mol Sci 2021;22:13295. [PMID: 34948091 DOI: 10.3390/ijms222413295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li W, Sun J, Zhou X, Lu Y, Cui W, Miao L. Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy. Front Pharmacol 2021;12:780790. [PMID: 34867412 DOI: 10.3389/fphar.2021.780790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
14 Kawanami D, Takashi Y, Muta Y, Oda N, Nagata D, Takahashi H, Tanabe M. Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Front Pharmacol 2021;12:754239. [PMID: 34790127 DOI: 10.3389/fphar.2021.754239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sugita E, Hayashi K, Hishikawa A, Itoh H. Epigenetic Alterations in Podocytes in Diabetic Nephropathy. Front Pharmacol 2021;12:759299. [PMID: 34630127 DOI: 10.3389/fphar.2021.759299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Kholia S, Herrera Sanchez MB, Deregibus MC, Sassoè-Pognetto M, Camussi G, Brizzi MF. Human Liver Stem Cell Derived Extracellular Vesicles Alleviate Kidney Fibrosis by Interfering with the β-Catenin Pathway through miR29b. Int J Mol Sci 2021;22:10780. [PMID: 34639119 DOI: 10.3390/ijms221910780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Srivastava SP, Srivastava R, Chand S, Goodwin JE. Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals (Basel) 2021;14:751. [PMID: 34451848 DOI: 10.3390/ph14080751] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]